StockData
Savara Inc logo

Savara Inc (SVRA) stock

SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$4.72+0.24 (+5.36%)

Close on Nov 18, 2026Market cap $969.77MP/E –Yield –

Savara operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Savara's operating cash flow for the twelve months ending Jun 30, 2026 was -$110.38M. For fiscal 2025 it was -$101.04M. The highest annual figure on record is -$4.78M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$101.04M–
FY2024Dec 31, 2024-$89.09M–
FY2023Dec 31, 2023-$51.06M–
FY2022Dec 31, 2022-$34.55M–
FY2021Dec 31, 2021-$40.08M–
FY2020Dec 31, 2020-$39.84M–
FY2019Dec 31, 2019-$45.12M–
FY2018Dec 31, 2018-$39.28M–
FY2017Dec 31, 2017-$28.23M–
FY2016Dec 31, 2016-$8.37M–
FY2015Dec 31, 2015-$4.78M–
FY2014Dec 31, 2014-$24.65M–
FY2013Dec 31, 2013-$17.79M–
FY2012Dec 31, 2012-$13.92M–
FY2011Dec 31, 2011-$13.47M–
FY2010Dec 31, 2010-$8.34M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$29.75M–
Q1 FY2026Mar 31, 2026-$33.05M–
Q4 FY2025Dec 31, 2025-$25.06M–
Q3 FY2025Sep 30, 2025-$22.53M–
Q2 FY2025Jun 30, 2025-$26.26M–
Q1 FY2025Mar 31, 2025-$27.19M–
Q4 FY2024Dec 31, 2024-$23.28M–
Q3 FY2024Sep 30, 2024-$22.67M–
Q2 FY2024Jun 30, 2024-$22.50M–
Q1 FY2024Mar 31, 2024-$20.64M–
Q4 FY2023Dec 31, 2023-$15.60M–
Q3 FY2023Sep 30, 2023-$13.16M–
Q2 FY2023Jun 30, 2023-$10.27M–
Q1 FY2023Mar 31, 2023-$12.03M–
Q4 FY2022Dec 31, 2022-$8.65M–
Q3 FY2022Sep 30, 2022-$8.16M–
Q2 FY2022Jun 30, 2022-$9.32M–
Q1 FY2022Mar 31, 2022-$8.43M–
Q4 FY2021Dec 31, 2021-$9.36M–
Q3 FY2021Sep 30, 2021-$8.93M–
Q2 FY2021Jun 30, 2021-$12.19M–
Q1 FY2021Mar 31, 2021-$9.60M–
Q4 FY2020Dec 31, 2020-$12.30M–
Q3 FY2020Sep 30, 2020-$6.71M–
Q2 FY2020Jun 30, 2020-$7.75M–
Q1 FY2020Mar 31, 2020-$13.08M–
Q4 FY2019Dec 31, 2019-$9.95M–
Q3 FY2019Sep 30, 2019-$11.41M–
Q2 FY2019Jun 30, 2019-$12.91M–
Q1 FY2019Mar 31, 2019-$10.86M–
Q4 FY2018Dec 31, 2018-$10.49M–
Q3 FY2018Sep 30, 2018-$8.76M–
Q2 FY2018Jun 30, 2018-$10.35M–
Q1 FY2018Mar 31, 2018-$9.67M–
Q4 FY2017Dec 31, 2017-$9.47M–
Q3 FY2017Sep 30, 2017-$8.25M–
Q2 FY2017Jun 30, 2017-$7.67M–
Q1 FY2017Mar 31, 2017-$2.84M–
Q4 FY2016Dec 31, 2016-$2.19M–
Q3 FY2016Sep 30, 2016-$2.87M–

More Savara figures

See a number that looks wrong?